| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |